Problem

Healthcare data is fragmented across proprietary EHRs, health-information exchanges, pharmacies, laboratories, and provider portals, making it difficult for clinicians and digital-health companies to obtain a complete patient history. The traditional process can involve calling multiple facilities, requesting records by fax, waiting weeks, and manually reviewing hundreds of pages to identify medications, diagnoses, laboratory results, and recent encounters. The economics are unattractive: direct integrations require substantial engineering, compliance, and maintenance work, while industry estimates put custom HL7 projects at roughly $50,000 to $750,000 or more, with significant ongoing maintenance costs.

Metriport’s clearest use case is automating clinical-record retrieval for technology-enabled and telehealth providers. After a patient books an appointment, the platform can gather records across the patient’s care history and make them available to the provider in minutes rather than requiring staff to chase and digitize records manually. This supports chart preparation, care transitions, medication adherence, referral coordination, and avoidance of duplicate tests, while reducing administrative burden at the point of care.

Product / Service

Metriport provides an open-source, universal healthcare-data API and associated dashboards. Its FHIR-native Medical API connects to major health-information networks—including CommonWell, Carequality, and eHealth Exchange—as well as EHRs, pharmacies, laboratories, and other sources. It retrieves data for more than 300 million people in the United States, then converts, standardizes, deduplicates, consolidates, and enriches the records into FHIR, C-CDA, PDF, longitudinal summaries, and other clinician-usable formats. Applications can receive results through webhooks or query them through the API, while providers can use the dashboard for record retrieval and exploration.

The delivery model combines a hosted SaaS service with open-source code that customers can inspect, customize, and potentially self-host. Metriport also offers a FHIR Converter for translating formats such as C-CDA into FHIR R4, and enables organizations to contribute new clinical data back to the networks. The intended benefit is to replace many point-to-point integrations with one connector, reducing implementation time from months to hours, avoiding vendor lock-in, and giving healthcare organizations more transparent and adaptable interoperability infrastructure.

Market

Metriport competes in healthcare-data interoperability and clinical-data exchange infrastructure, selling primarily to digital-health companies, technology-enabled providers, telehealth organizations, and healthcare organizations that need access to records across disparate systems. Directly identified competitors include Holon Solutions and Moxe Health; the broader category also includes proprietary healthcare-API and integration vendors. Metriport’s principal differentiation is its open-source approach, alongside its FHIR-native architecture, network coverage, data normalization, and ability to write new information back to healthcare systems.

The available evidence indicates that Metriport is operating commercially rather than being merely pre-revenue. It raised a $2.4 million seed round at a reported $20 million valuation in December 2022 after participating in Y Combinator’s Summer 2022 batch, and by October 2023 had named customers including Circle Medical, LunaJoy, and HospiceMatch; its platform had also been used in beta by dozens of companies. Its public GitHub repository showed 752 stars and 104 forks in the retrieved evidence, and the company site features a Tono Health case study. A third-party directory estimated approximately $5 million of 2024 ARR, but that figure is not an official company financial disclosure, so the strongest verifiable traction is the funding, named customers, beta usage, public open-source adoption, and continuing product availability.